Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 209

Similar articles for PubMed (Select 12911685)

1.

In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes.

Takahashi K, Uejima E, Morisaki T, Takahashi K, Kurokawa N, Azuma J.

J Clin Pharm Ther. 2003 Aug;28(4):319-27.

PMID:
12911685
2.
3.

Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes.

Park JY, Kim KA.

Eur J Clin Pharmacol. 2003 Sep;59(5-6):407-9. Epub 2003 Aug 5.

PMID:
12904931
4.

In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms.

Lee HW, Kim DW, Phapale PB, Lim MS, Park J, Seo JJ, Park KM, Park YK, Yoon YR.

J Clin Pharm Ther. 2011 Aug;36(4):496-503. doi: 10.1111/j.1365-2710.2010.01201.x. Epub 2010 Aug 24.

PMID:
21729114
5.

Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.

Or PM, Lam FF, Kwan YW, Cho CH, Lau CP, Yu H, Lin G, Lau CB, Fung KP, Leung PC, Yeung JH.

Phytomedicine. 2012 Apr 15;19(6):535-44. doi: 10.1016/j.phymed.2011.12.005. Epub 2012 Jan 18.

PMID:
22261394
6.

Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract.

Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T.

Drug Metab Dispos. 2004 Dec;32(12):1351-8. Epub 2004 Sep 1.

7.

Effects of Kampo medicines on CYP and P-gp activity in vitro.

Ito K, Satoh T, Watanabe Y, Ikarashi N, Asano T, Morita T, Sugiyama K.

Biol Pharm Bull. 2008 May;31(5):893-6.

8.

Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba.

Liu KH, Kim MJ, Jeon BH, Shon JH, Cha IJ, Cho KH, Lee SS, Shin JG.

J Clin Pharm Ther. 2006 Feb;31(1):83-91.

PMID:
16476124
9.

Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively.

Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ.

Drug Metab Dispos. 2002 Jun;30(6):631-5.

10.

Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.

Wang X, Cheung CM, Lee WY, Or PM, Yeung JH.

Phytomedicine. 2010 Sep;17(11):868-75. doi: 10.1016/j.phymed.2010.05.003. Epub 2010 Jul 16.

PMID:
20638257
11.

Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes.

Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S.

Life Sci. 2004 Apr 16;74(22):2769-79.

PMID:
15043991
12.

Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes.

Nakamura K, Ariyoshi N, Iwatsubo T, Fukunaga Y, Higuchi S, Itoh K, Shimada N, Nagashima K, Yokoi T, Yamamoto K, Horiuchi R, Kamataki T.

Biol Pharm Bull. 2005 May;28(5):882-5.

13.

Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes.

Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y, Ai H, Wang G.

Drug Metab Dispos. 2008 Jul;36(7):1308-14. doi: 10.1124/dmd.108.021030. Epub 2008 Apr 14.

14.

Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.

Micuda S, Mundlova L, Anzenbacherova E, Anzenbacher P, Chladek J, Fuksa L, Martinkova J.

Eur J Clin Pharmacol. 2004 Oct;60(8):583-9. Epub 2004 Sep 16.

PMID:
15378224
15.

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.

Derks M, Fowler S, Kuhlmann O.

Curr Med Res Opin. 2009 Apr;25(4):891-902. doi: 10.1185/03007990902790928 .

PMID:
19245299
16.

Involvement of CYP2C9 and UGT2B7 in the metabolism of zaltoprofen, a nonsteroidal anti-inflammatory drug, and its lack of clinically significant CYP inhibition potential.

Furuta S, Akagawa N, Kamada E, Hiyama A, Kawabata Y, Kowata N, Inaba A, Matthews A, Hall M, Kurimoto T.

Br J Clin Pharmacol. 2002 Sep;54(3):295-303.

17.

Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes.

Zhang JW, Liu Y, Li W, Hao DC, Yang L.

Eur J Clin Pharmacol. 2006 Jul;62(7):497-502. Epub 2006 Apr 28.

PMID:
16645869
18.

Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.

Lieu C, Shi J, Donat F, Van Horn R, Brian W, Newton J, Delbressine L, Vos R.

Clin Pharmacokinet. 2002;41 Suppl 2:19-26.

PMID:
12383041
19.

In vitro inhibition of Huanglian [Rhizoma coptidis (L.)] and its six active alkaloids on six cytochrome P450 isoforms in human liver microsomes.

Han YL, Yu HL, Li D, Meng XL, Zhou ZY, Yu Q, Zhang XY, Wang FJ, Guo C.

Phytother Res. 2011 Nov;25(11):1660-5. doi: 10.1002/ptr.3475. Epub 2011 Mar 21.

PMID:
21425377
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk